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• Apoptoals and Early Necrosis In Perltransplant 
Ischemlc Injury andAcuta Allogralt Rejection In 
Human Heart ~ansp lant  Recipients 
J,D, Day, R, ORe, U, N~raslmhnn, S, Oopnt, M,T, Day, EK, K~spor, 
C,.L, Chon, ~,J, Cinn, A,L, Rebedson, R,H, Hruben, SfanfoM Un/vemily 
Hob#/fat, Stanford, CA: The Jottn~ Hopktn,~ Medical Insfiluftens, Eta/timers, 
MC~ USA 
~,~ckground; Coil cloath may ouour by apopto~ or noorosis, Apoptosls is a 
phy~lolOglo process for disposing Dells through orderly soil deotruoflon, while 
no~rosls results from cytolytlo oh~ngos following Doll miss/ WQ nssos.~od 
their p~ttom aed extonl ~n m~,l~tlple samp~ ~a fre~~ ;~9 p.',ient ,~ 
M~lhpd~; Apoptosio was doto(;tod by in sih4 er~d labeling and n(l~l~ar 
cl~mm~ftn ~lalntng and neorosts tmmunohlstochomt~dly using a ooniug=Ued 
myosin light chain monoclonal ~ntibody, Accompanying tnflsmmalery infil. 
trains were Id~nttflod by tmmgnop, rexidasa staining of lymphncvle subsets 
Rosult~ were oompared with clinical doln ~nd re~dlnn hem~toxylin.~esln 
evaluation of ondomyocnrdh~l btopslns, 
RP,qUII~: Apoptosta was Identified at tbe perlphoq/of the isel~amlc to0i 
in 75% of the biopsi¢ls that showod peri(ransplant lachemic mltlry by Iigl~t 
mtoros~opy, whllo ~mmt!noh(~tochnmloal slolnlng for myosin light ohain leNly 
nocrests) was obsontod within the cores of ~11 lschomic loci, Apoptottc my. 
DO/los w~re observed In 90% el the blopsteS which showed aouto rejection 
and immunohtstochomlcnl staining for myosin light chain was obeowod in 
86% el those btopstea Endy myocyto necresls waa dotoctod in 70% Of the 
bl0psi0S ovakmted without necrosis by reutlne I~lslologle grading (Grade tA 
• relo¢tlon), 
Cor~lusipn: Slgnllieant myncyto cell death In the term el both apoptoscs 
and eady nacrests ocours in porttransplant ischemic Injury and ;n acute silo. 
grell mloctlon, The idnnllticOtlo r' nl Irrevor~Ibln i troeolMar myosin release 
by the use of monoclonal myosin light chain antibodies In tissue sections 
proved to be a sensitive techmque for detecting the earliest stages el local 
m,/ocyle ~ms(s. 
"~ of Mild In Steroid-free The Meaning Rejection 
Heart Transplant Recipients 
JA. Kobeshlgawa, K. Einhom, TK. Re, JD, Cassom, J,D. Morigocht, 
MA Hamilton, A Hope, N Kawafa, H Lake. Umverslh, of Cahtornia. Lo.~ 
An.c/elo.,~, CA, USA 
It has boon reported that todd reiection (rsi) tn heart transplant patients 
progresses to a more severe form of roj in 10-20% of follow-up blopst0s. 
Many patients are now being weaned from corttcostoretds and it has not 
been established whether mild rej has a similar outcome in these patients, 
To assess the natural htstont of untreated mild (ISHLT 1A, 1 B) and untreated 
focal moderato (ISHLT 2) rej in patients off corticosloreids, we reviewed 
106 patients transplanted between 4•86 and 9/95 with an average time from 
transplant lo corticosteretd-freo tmmunosuppmaslon f 20 t 10 months. In 
those patients, there wore 126 episodes el untreated mild and local moderate 
rei with outcemos demonstrated in the table. 
Episodes Nexl Biopsy 
N CIoorod Pe~'SisIed Pro0ros~od 
1A 91 67 (74%) 2~ (24%) 2 (2=0) 
113 14 I '7%) 10 (71%~ 3 (220.) 
2 2.1 15 (71"o) 4 (19%1 2 (10%) 
Moderate rei was eventually seen in those "persisted" rei episodes in 
the following incidence: 1/22 grade 1A episodes, 1/10 grade 1B episodes, 
and 0/5 grade 2 episodes. Therefore, in patients with 1B rej, a total of 4/13 
episodes (31%) progressed to moderate rei which required anti-relection 
therapy. During the time ot fhts study, there were 198 abnormal hiopsies 
(includir,g all Desisted reis) out ol a tolal of 845 biopsies performed (23%). 
Conclusion: Cardiac transplant patients who are on steroid-tree immune- 
suppression should have careful fogow-up if their ondomyocardial biopsies 
demonstrate 1B rejection. ISHLT 1A and 2 biopsy gradss appear to have 
lower risk for progression to moderate rejection. Surveillance biopsies may 
be necessary to detect rejection in these patients maintained off corlicos- 
toroids. 
• Predictive Modal to Coronary Asso~s Risk for 
Artery Disease attd Graft Fellure In Cardiac 
Alfogrsft Recipients: An Immunocyfochsmlcel 
Study 
C,A, Labarrem, D.R, Nelson, D.E, Plffs, P,C, Klrlin, H, Halbrook, C/arian 
Health (Methodist, Indiana Uniwrsity, Riley Hospitals), Indsanapolis, 
Indiana, USA 
B~ckgmund: We dev~lopsd a model for endy idenliticaflon el ro¢ipient~ 
wile subsequently dnvelep transplant.associated coronary adory disease 
(Tx,CAO) and graft failure, 
Me.rhode: Serial blopslos obtained from 121 cnrdiao allograMs (55 :t 0,1 
blopsioalpntlent) during the fi~t three months post.tron~plnnt wnm ovatu~t~l 
for deposition of microvascular libnn, depletion of ad~olsr tissue pl~smino- 
pen activator, pmsonoo el adorinl/aderieIRr endotholiat activation roarkere 
ICAM.t and HLA.DR, and changes in vasoular antithrombin, An immunoo/. 
tochemlcal risk acorn fIRS) was studied for fmsO¢ieltion with subseqtrent grail 
foiltlm and develepmonf ~lnd progression el Tx-CAD detail, led using senal 
corena~ angionmm,~ 13,2 t 0,PJpationl), 
Rosvlls: AIIoqrefts wilh low IRS (scorn ~ 0) developed significantly less 
TxCAD (p - O,qOl) lhan allegretto with moderato {score = 0.5-,~3.0) or 
hii]h (score = 3,fi~4.0) IRS The disease progressed in P~,, tP~ and 44% 
of allegretto with low, moderate and high IRS, respectively lP - 0.001). 
Allegretto with low IRS h~d sigo(ticantly less gram failure (p ~ O001) than 
allegretto with moderate r high IRS. 
Cor~t¢tsl(ln: Early (~hangos in the micrevasculatum am assoCiated with 
impending Tx.CAD and gram failure in cardiac allogratt reOpmnts. 
~ Oetectlon AntI-HLA Antibody byFIow of 
Cyfomstry In Patients Wllh s Left Ventr!cular 
Assist  Oevlce Is Asso©!Mlld With Early Relm:tion 
Following Heart Transplantation 
D. OeNolrio, F,-J. Morales, M. Kamoun, J. Koams, C. Dorezinsky. 
OR, Rosengard, M,A Ackor, E. Loh. Unlversl~" nf Pennsylvania/-k~ffh 
System, Phllad~l,)hla, PA, USA 
Patients squiring a tell vontncular assist deride (LVAO) as a bridge 10 heart 
transplantation (HT) olten have elevated levels el panel reactive ant~bodms 
(PRA). The clinical significance of anti-HLA antibodies detected by flow 
cytomotn/in PRA negative patients remains unclear. Eighteen patients who 
underwent LVAD placement as a successful badge to HT had simultaneous 
flow cytomelry and standard anti.human globulin complement Dependent 
cytotoxicity (AHG-CDC) assays portormed to detect anti.HLA antibodies. A 
positive flow result was defined by a ItuoresCont ratio of ;3:1 vs controls. 
Two patients with a pas~tivo PRA and one pattent with panoperative death 
seconda~, to relractory pulmona~t hypertension were excluded. The study 
population (n = 15) had a moan ago of 44 t 15 yrs, 88",, were male. and 
the mean duration of LVAD support was 94 t 53 days. In patients with 
anti-HLA antibodies detected by flow cytometnt (n = 6). univa.ato analysis 
demonstrated mere mederate-sevore rejection episodes (ISHLT ~3A) at 2 
months (0.83 ~. 035 vs 0: p = 0.04) and a trend towards decreased time 
to first releclion (61 * 17 days vS 225 ~ 62 days: p = 0.06). No diNerences 
in donor recipient HLA mismatch or Kaplan-Meier survival at one year were 
observed 
Conclusions: Despite a negative PRA. LVAD patients with anti-HLA an- 
tibodies detected by flow cytometn/have a greater incidence ot moderate- 
severe reiection in the hrst 2 months tollowing HT. Flow cytometn/may be a 
useful clinical tool in screening PRA negative LVAD patients prior to trans- 
plantation. Patients with positive flow cytometry may require more intensive 
immunosupprossion i the early post-HT penod. 
• Effective Long-term Methotrexate Therapy for 
Acute AIIograft Rejection After Heart 
Transplantation 
G.M. Mullen, M.A. Silver, C.E. Lawless, J. Mendez, P.C. Barath, 
K. Malinowska, B.A. Pisani, J.A. Robinson. Loyola University of Chicago. 
Heart Transplant Program, Maywood, Illinois. USA 
In spite el progress in im,'nunosuppressive therapy, acute allograft rejection 
(AAR) still rereains a major cause el death and allogralt dysfunction alter heart 
transplantation (HT). Standard "triple-dnJg* immunolherapy (cyclosporine, 
azalhioprine and predntsoile) is effective against most, but not all AAR. 
Other adlunctive agents such as methotrexato (MTX) have been used to 
decrease frequency and severity of AAR, but its long-term effectiveness is 
unknown. We retrospectively reviewed 366 HT recipients of whom 34 had 
received MTX for AAR. We then divided patients into two groups based on 
AAR grade using a weighed numerical scale, Group I (<3) and Group !1 (-3). 
JA('(" F~:hnmry IqqX AB.~TRA('I'5 |=¢~Icf ~SA 
Gmup I (N = ~O) Group II (;MI 
Sex 2 Fen~te~8 M,~le S Feme~o/19 M~le 
Age (yOatSl 4.5 67 ~ 13 97 51 83 ~ t0 52 
AAR Glade 1 5 , 0 73 365 ~ O 7.5 
C~r~q~clnde~n MTX 336 ~ 1 26 246 = 007 
I Yem Sgwneat t00 100 
5 Yem ~va l  I~13 83 3 
One y~ar and bye yearn survival in the ~ patlents who d~d not receive 
MTX was only 82 .~"  aod 66%', re~pe~welv, 
CO~'ll~3r~l: Lof1~t~r~ SUfV!val in those FiT p¢lt~nts with hemedynan'.e 
¢omp~ and htgh AAR grad~ who received MTX wa~ e~collent (Group 
Ill, The Iong-t~ml sgnnval in kit patents with lower AAR grackl) (Gfou~ I) 
was also excellem, MTX ~, an etle¢twe ar~ sate agent *n the maf~gement 
el AAR efl~ HT. 'p • 001 
~ Comb!nation With T l~ l lmul  and 1'Mf~py 
=Mycopheno!M~ MO~I  in Heart Tmnllplantation 
~ t s  ~ Completely 
B.M Mmsef. M. Plelffe~, M. Ja~pello~Kraalz, D Schm~dl, P Ubeduh~, 
H Rs~-henspumm, Wv. Sche~t, B. Re~charL Ur~ers~otMun~ch. ~1366 
~roun~:  In a recent study ~onduded at om centre MMF was ao~n~nts~ 
tere¢l at a ttzeG dose el ~ ojda~y m Coff~natton vath tac~'olim~ and corti~ 
costero~ls m 15 hear transplanta~on pal~ents. The results showed that the 
~mmunosuppress~'e et~=cy ot MMF stmeg~ coeetatnd ~ me blood con- 
centration TherefOre. we condUcled a second study m ~ the MMF ck~se 
was a~usted according to t~OCt ,.u, =~r~ratmns. 
~c~s:  Tl~rt~ patNents were e~mned The mean donor and reop~nt 
ages were 39.6 ~ 13.0 and 54.0 : 9.0 years, respecln,'e~, the mean =s- 
C ~  time was 180 : (~ n~n. I~ . '~  tacre l~ was adeltn=stered 
mnme~ately post-b'ansl~antation to~ 24-48 hours lollewed by oral tacrolimus 
to. a target blood concentralmn range o! 13-15 n(31~nl MMF was a~rt~,~s- 
temd at an ~nmal dose of 2 g/d and adlustnd fm tablet concentratmns at 
2.5.-4.0 ~,~,nd. The mean ,=,.'MF Uoc, e was 3 1 ~ I I g/d (range: 0.5-6 o,'d) 
Resu~s: Patmm survwal was 97%, one pal;enl d=ed of a pulmonary mtec- 
tmn An pa~=nts, excepl one. were free of am.,te ~ (0 03 AP,~I~'~) 
Tt.s patient had been suflenng h'om influenza .nth severe gast~(.nles~nal 
and had a laoroliP~J:~ blood Oo~c~rttrat~ll Of5 noJ1111 ~ an MMF 
bk~od COnCentrahon el 0.5 ,,~rt~ at the time el I~cosy (Grade 3A. ISHLT 
Grade) StereOs have be~n coml~etely ~ tram all ~ who 
completed 6 monms el the SB~y The mean obser~abon period was 152 ,,- 
60d. 
Conc~Km Our result~ suggest that comt~nal~on therapy w~ tacrohmus. 
MMF. and sic, rods seems to p~even! acute mlect~n completely ~flen ~e 
MMF and lacrohmus doses w~re a~lusted to wdnm the t~rget ranges Thus 
- contrary to what has been recommended earher - MMF (Jose ad/ustments 
accon~ng to the blood concec, hebon seem to ~mpre~ outcome sugntftcantty. 
This strategy at'so alk~s complele v,'qhdmwal of steretds 
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I 1 O1 7 -167 ] Can Adenos ine Ti lt  Testing Replace 
Conventional  Tilt Testing? 
S~ Mittal. S Rohatgt. KM. Stein, S.M Markowttz, D.J. Slotwmer. 
BB  Leeman. The Net). York Hospitat.Comeff Urnvers~ Meo~a! Center. 
N~v York. NY. USA 
Backgmur~/: Adenosine (ADO) can tngger a vasodepressor esponse dunng 
tdt testmg (T'r). We compared ADO "[1" versus conventional (Cony) 1"1" in 80 
consecutive pts with pre-synCope anger syncope (34 M;46 F, 53 ~. 21 years,', 
undergoing "~'. No pt was on t~-blockers. 
Methods: Pts received ADO (12 rag) while upngtit and were observed 
for 5 rain. All pts developed initial bradycardia anger AV block followed by 
a reflex tachycerdia. A positive response was defined by a symptomatic 
vasodepmssor rest:lense following the reflex tacbyca~ia. Alter returning to 
the supine position, all pts. regardless of the response to ADO. undep~vent 
Cony fT. t- =-~ were tilted upnQht at 60 °. for 30 rain: it neoj~tive, pts under~.~nt 
a 15 rain upnght TT dunng isopreterenol (ISO) inlusion (1-5 i,g/min until the 
heart rale increased by 20% compared with baseline). 
Retuffs" The yield of ADO "IT (16t80. 20%) was similar to Conv 1"1" (17/80, 
21%. p = NS). The yield increased to (27180 34%) when either a post)we 
ADO "IT or Cony Tf  was cons~rnd a pesmve lest Ot the 10 pls w~n a 
negative ADO TT and a pos~l=ve Cony T'T, 7 (70%) rescues<! =soprot~l  
dunng Cony 1'3' to pm<kce a I~os~tive r sponse 
Conclusions' (1) The overall ytelcI el ADO TT =s compMable tO Cony TT 
(2) Because n ts s~mpler and less tin~ consuming to I~:~rm than Ctmv TT, 
ADO TT should I~ per~om~l intt~llly in all pta ufl¢l~c,,,-,~ TT A ~ e  
ADO TT o~tales th~ ~ tot turlf~f Cofw TI" (3) To I11=xtPmz~ the WMtl Ol 
TT, pts with a negativ~ ADO 1~ should undergo a, ~ w~h ISO for 15 mint f,~. 
~ Aort ic  M~hen lc t  Ourln9 Tilt-up trod:  Insight= 
into the Me0hln lern|  In~lv~l  th 
Neuroesrdk,  g in le  Syn~pe 
K Ga~zouh~, C. Stelana~s, C. VkChopoutoe, E, Ts~mw, S S~m=, 
A Theop~stOu. K Toutouzae. M Vavouremakm. t Gmlatos. P Toutouzu. 
e-kopokratmn Ho~p~ae. Arner~ ~n~ AI1~e~. Greece 
Ba¢'kgmunc!: "the p r ~  mech ~ cm of ne~irncarC, oger~ ayr¢ol~ t~ an 
intense vag0tonm mac1~on leading to a ralhe~ ~t.~dden cafdlomh,t~tion, and/0r 
vaso~laf~o~. The vasoddatoty reacllon *s pmsumab~ due 1o ~ el the 
a~enal IOn~ Howe~er, fhe changes m ao (Ao) wall tone have not been 
invest~ted 
M~.  We evaluaMd the Ao wall mecfiamcs dunog syncope reduced 
by til~mg m 5 ptS pcesentlng wffft syncope el unknown et~oIoQy All 5 pts (a~e 
35 ~ 7 ym) pmsemed w~th at least om~ documente~ el~so~e o! syncope not 
assooatnd web an ¢let~t~l anhythm~c m mecha.,mc~ cardiac cause afle~ 
a momugh ele¢lropl~ys~ologK;al evalualmn The tilt-up lest was pedormed 
m the 80 ~ upng~ pos~t~ tot a total o~ 60 ram. o~ t.,~l p ~  due 
to h~otensmn or bradycae~a nccumee AO ~ prope~=~ were evalu. 
ated by pressure (P~l~an',et~ (ID) re~tm~ obtame~ from the earnulta ~.~-~. ~ 
rece~ngs ol the Ao O and Ao P. Ao D was measurea by an u l t~ d~. 
mensmn intravascular catt~Im deve~ m our tnstttutmn (Cm."utaP, on 1995; 
92: 2210-9) . /~o P was recorded by a Miller ter. 
~ :  In 3 pt~ the test was posttNe and in 2 negative In the pts 
lesl the P-D retatmn cnange~ mgmficanby mdcat]ng improved etastm 
pml~erbes dunng pmsyncope {fig.), whereas they remame~ unchanged m the 
pts ~nth a negative test. 
IB~dine 
tt 12 t3 14 t5 1(I t7 t6 
Diam~¢r ( ram)  
Conclusions: AO elastic prope~,es are s~gnst~cantly improved dunng neu- 
rocard~Qgen~ syncope, md~3tlng changes tn Ao wall tone This tind~ng may 
pro~de a better understating ot tt,,e mechanisms revolved m neurocantlo- 
ger,c syncope 
~ Baromceptor  Function Outing Heed-up Tilt in 
Patients With Neurocardiogenic Syncope 
MV P~tzabs. A. Passantino, N. D~ Venere, C. Forleo, F Massan, P. Tolam, 
F Ma~ropasqua. P. R~..zon. Cardiology. Ban Unn, ets~, Italy 
Background: The pathophysmlogy of neurocardioge~C syncope ~s not com. 
p~etety ur~wsto~d This mudy was a~,Omssed to eva~uate the potable role 
el an alteramd barerefle~ sensd~ty (BRS) 
Me)heels: We studie<:l 13 sublects (30 : 4 yrs) w~h -.3/year syncopes. 
and a head-u~ tilt test (TUT) pes=twe for neuroca~togenm syncope who 
were compared Io 22 normal subjects (28 : 10 yTS) (Control) In both groups 
ECG and systolm blood pressure (SBP) were recorde~ before TUT in supine 
posJt~on (BS). an~ througr~oul tt~o TUT The recordings dotamnd from BS end 
the flrsl 5-rntnutes el the postt~vo TUT were analysed. BRS was evaluated by 
using the sequenC'~ method which revolves lhe ~dentttcat~on f sequences 
.3 beats dunng which RR and SBP mcmaSnd or decreased concurrently 
Tfie mean regress)on st~pe tietween RR and SBP was considered an index 
of BRS (msec/mmHg) Mean value of BRS and the percenlage 0f beats 
involved m a sequence (Peru) were calculat~L 
Results: 
PaPents Control p 
BRSBS 14 7 ~ 6 t 178 : 9 t ns 
BRS TUT 69 :- 3 9 5 : 3 ns 
Pete BS 45 : 12" .52 : 18 ns 
Perc TUT 39= 12 54±9 005 
• P . 0.05 BSvs TUT. t p . 001BS vs TUT 
Conclusron: Dunng ;.~e eady rr,:nu~es el posit ive , '~'T,  pat;cnts who v,ll l  
